Study 2 of 47 for search of: "Aphasia"
Previous Study Return to Search Results Next Study

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Neural Networks and Language Recovery in Aphasia From Stroke: fMRI Studies
This study is currently recruiting participants.
Verified by Department of Veterans Affairs, August 2008
Sponsors and Collaborators: Department of Veterans Affairs
Boston University
Information provided by: Department of Veterans Affairs
ClinicalTrials.gov Identifier: NCT00467103
  Purpose

The purpose of this research is to utilize functional magnetic resonance imaging (fMRI) to investigate brain reorganization for language behavior in stroke patients with aphasia. A primary focus of the study is on recovery of nonfluent propositional speech and naming in chronic aphasia patients. The fMRI technique is used to examine activation in the left hemisphere (LH) and right hemisphere (RH), during recovery of specific language behaviors in chronic nonfluent aphasia patients.


Condition
Aphasia
Nonfluent Aphasia
Stroke

MedlinePlus related topics: Aphasia MRI Scans
U.S. FDA Resources
Study Type: Observational
Study Design: Cohort, Prospective
Official Title: Neural Networks and Language Recovery in Aphasia From Stroke: fMRI Studies

Further study details as provided by Department of Veterans Affairs:

Primary Outcome Measures:
  • Cerebral Activation in the Left and Right Brain Hemispheres [ Time Frame: Out to 6 months, from baseline entry ] [ Designated as safety issue: No ]

Biospecimen Retention:   None Retained

Biospecimen Description:

Estimated Enrollment: 80
Study Start Date: October 1999
Estimated Study Completion Date: March 2011
Estimated Primary Completion Date: September 2010 (Final data collection date for primary outcome measure)
Groups/Cohorts
1
Chronic Stroke patients with Nonfluent Aphasia
2
Age-matched Normal Controls

Detailed Description:

PURPOSE: The purpose of this 4-year fMRI research is to study brain reorganization for language in patients with left hemisphere (LH) stroke who have chronic nonfluent aphasia. This fMRI research is fundamental and critical to the PI's NIH RO1 grant, Transcranial Magnetic Stimulation (TMS) to Improve Speech in nonfluent aphasia, which was recently renewed for 5 years, 2006-11. There is no overlap in the studies. The NIH grant provides the TMS (real and sham). This VA grant provides 4 different fMRI tasks performed pre- and post- a series of TMS treatments (real and sham) - Overt Naming fMRI; Overt Propositional Speech fMRI; and Nonverbal Semantic Decision tasks for Nouns, and for Actions.

We have observed that application of TMS to an anterior portion of right (R) Broca's homologue (pars triangularis, PTr), results in significantly improved picture naming ability at 2 and 8 Mo. after the last (10th) TMS treatment, in aphasia patients who began TMS at 5-11 years poststroke. Also, half of these nonfluent aphasia patients improved their Phrase Length in propositional speech, post-TMS.

RATIONALE: We and others have observed that patients with chronic, nonfluent aphasia (poor, hesitant speech) have overactivation of R hemisphere (RH) cortical language homologues. We hypothesize this represents a maladaptive plasticity and probably poor active inhibition during speech. Slow, 1 Hz TMS can be used to suppress cortical excitability. Our goal is to use 1 Hz TMS to inhibit/suppress the overactivation in RH language homologues. Our early TMS research has shown that suppression of R PTr in these patients is associated with improved speech. The fMRI studies proposed in this VA grant will help to investigate the neurophysiological changes underlying improvement post- TMS in propositional speech and in nonverbal semantic decision tasks. The new MRI technique, diffusion tensor imaging (DTI) will be used to study WM pathways subjacent to cortex treated with TMS.

DESIGN: Randomized, sham-control, incomplete crossover design with 32 patients (16 mild-moderate; 16 severe nonfluent), half receive real TMS series only; half, sham TMS 1st, and real 2nd. Language, Neuropsych. testing, and fMRIs are performed at Entry, and at 2 Mo. post-10 real or sham TMS treatments; and at 6 Mo. post real. There are 4 Projects: 1) fMRI during overt naming and propositional speech (Overt Picture Naming and Picture Descriptions/Story Telling; 2) fMRI during a Nonverbal Semantic Decision Task with Superordinate Noun Icons; 3) fMRI during a Nonverbal Semantic Decision Task with Action and Object Icons; 4) DTI. DTI is performed only at Entry (all subjects). Normal controls (n=8) do not receive TMS; they are studied with fMRI at Entry, at 2 and 6 Mo. later.

HYPOTHESES: Following the real TMS to suppress R PTr, there will be less overactivation on fMRI (better modulation) in RH language homologues, and new LH activation (including L perilesional areas and L SMA). This will be associated with improved propositional speech (BDAE) and nonverbal semantic decision ability at 2 and 6 Mo. post-real TMS. No language or fMRI changes are expected post-sham TMS. The fMRIs performed 3x with the normal controls are not expected to show change, but will document the neural networks for the fMRI tasks.

  Eligibility

Ages Eligible for Study:   45 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Chronic stroke patients with nonfluent aphasia

Criteria

Inclusion Criteria:

  • Aphasia patients with a single, unilateral, left hemisphere stroke.
  • Patients must be native speakers of English
  • Patients must be at least 6 months poststroke and produce mild-severe nonfluent speech. Minimum Language requirements: 2-4 word phrase length on elicited propositional speech
  • Auditory Comprehension a the 25th percentile or higher on the BDAE subtests for Word Comprehension and Commands, sufficient to cooperate during testing
  • The ability to name a minimum of 3 items on the Boston Naming Test at entry into study.
  • Patients must understand the nature of the study and give informed consent.
  • Normal right-handed controls with no history of neurological disease or substance abuse; age, education and gender-matched to the Aphasia cases.

Exclusion Criteria:

  • Patients with more than one stroke in the left hemisphere or patients with bilateral strokes.
  • Each participant must be able to have an MRI scan.
  • MRI is contraindicated for pregnant women.
  • Patients will be excluded if they have the following:
  • Intracranial metallic bodies from prior neurosurgical procedure, implanted pacemaker, medication pump, vagal stimulator, deep brain stimulater, TENS unit or ventriculoperitoneal shunt
  • Past history of seizures within one year or unexplained loss of consciousness Family history of epilepsy
  • Acute, unstable medical conditions
  • History of substance abuse (within last 6 months)
  • Abnormal neurological exam, other than as signs of the condition being studied
  • Abnormal MRI, or history of known structural brain abnormality other than as signs of the condition studied in the present protocol.
  • Administration of investigational drug within 5 halflives of the drug prior to testing.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00467103

Contacts
Contact: Paula I Martin, BS (857) 364-4029 paulak@bu.edu
Contact: Michael Ho, PhD (857) 364-2213 mikeho@bu.edu

Locations
United States, Massachusetts
VA Medical Center, Jamaica Plain Campus Recruiting
Boston, Massachusetts, United States, 02130
Contact: Gary Park, BA     857-364-6564     gary.park@va.gov    
Contact: Liza M Catucci, BA     (857) 364-6252     liza.catucci@va.gov    
Principal Investigator: Margaret Naeser, PhD            
Sponsors and Collaborators
Boston University
Investigators
Principal Investigator: Margaret Naeser, PhD VA Medical Center, Jamaica Plain Campus
  More Information

VA Boston Healthcare System Research Service Website  This link exits the ClinicalTrials.gov site
The Harold Goodglass Aphasia Research Center is a service of the National Institute on Deafness and Other Communication Disorders  This link exits the ClinicalTrials.gov site
Click here for more information about this study: Neural Networks and Language Recovery in Aphasia from Stroke: fMRI Studies  This link exits the ClinicalTrials.gov site
The Berenson-Allen Center for Noninvasive Brain Stimulation (CNBS) at Beth Israel Deaconess Medical Center and Harvard Medical School  This link exits the ClinicalTrials.gov site

Publications of Results:
Naeser MA, Martin PI, Baker EH, Hodge SM, Sczerzenie SE, Nicholas M, Palumbo CL, Goodglass H, Wingfield A, Samaraweera R, Harris G, Baird A, Renshaw P, Yurgelun-Todd D. Overt propositional speech in chronic nonfluent aphasia studied with the dynamic susceptibility contrast fMRI method. Neuroimage. 2004 May;22(1):29-41.
Martin PI, Naeser MA, Theoret H, Tormos JM, Nicholas M, Kurland J, Fregni F, Seekins H, Doron K, Pascual-Leone A. Transcranial magnetic stimulation as a complementary treatment for aphasia. Semin Speech Lang. 2004 May;25(2):181-91. Review.
Kurland J, Naeser MA, Baker EH, Doron K, Martin PI, Seekins HE, Bogdan A, Renshaw P, Yurgelun-Todd D. Test-retest reliability of fMRI during nonverbal semantic decisions in moderate-severe nonfluent aphasia patients. Behav Neurol. 2004;15(3-4):87-97.
Naeser MA, Martin PI, Nicholas M, Baker EH, Seekins H, Kobayashi M, Theoret H, Fregni F, Maria-Tormos J, Kurland J, Doron KW, Pascual-Leone A. Improved picture naming in chronic aphasia after TMS to part of right Broca's area: an open-protocol study. Brain Lang. 2005 Apr;93(1):95-105.
Naeser MA, Martin PI, Nicholas M, Baker EH, Seekins H, Helm-Estabrooks N, Cayer-Meade C, Kobayashi M, Theoret H, Fregni F, Tormos JM, Kurland J, Doron KW, Pascual-Leone A. Improved naming after TMS treatments in a chronic, global aphasia patient--case report. Neurocase. 2005 Jun;11(3):182-93.
Martin PI, Naeser MA, Doron KW, Bogdan A, Baker EH, Kurland J, Renshaw P, Yurgelun-Todd D. Overt naming in aphasia studied with a functional MRI hemodynamic delay design. Neuroimage. 2005 Oct 15;28(1):194-204. Epub 2005 Jul 11.

Responsible Party: Department of Veterans Affairs ( Naeser, Margaret - Principal Investigator )
Study ID Numbers: MHBB-006-06S
Study First Received: April 25, 2007
Last Updated: August 25, 2008
ClinicalTrials.gov Identifier: NCT00467103  
Health Authority: United States: Federal Government

Keywords provided by Department of Veterans Affairs:
Adult Aphasia
Diffusion Tensor Imaging
functional Magnetic Resonance Imaging
Language Recovery
Left Middle Cerebral Artery Stroke
Nonfluent Aphasia

Study placed in the following topic categories:
Speech Disorders
Cerebral Infarction
Aphasia
Aphasia, Broca
Stroke
Vascular Diseases
Central Nervous System Diseases
Language Disorders
Ischemia
Brain Diseases
Cerebrovascular Disorders
Signs and Symptoms
Infarction, Middle Cerebral Artery
Brain Ischemia
Neurologic Manifestations
Brain Infarction
Infarction
Neurobehavioral Manifestations
Communication Disorders

Additional relevant MeSH terms:
Nervous System Diseases
Cardiovascular Diseases

ClinicalTrials.gov processed this record on January 16, 2009